IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per plan. LAWRENCEVILLE, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinica ...
Sapanisertib combined with weekly paclitaxel improved PFS in platinum-resistant ovarian cancer, reducing the risk of death by 34% compared to paclitaxel alone. The combination therapy was generally ...
After managing two bouts of ovarian cancer, CNN's Christiane Amanpour reveals that she has it for a third time. 'I decided to ...
In April 2024, Willette was diagnosed with advanced lung cancer. She underwent surgery the next month, a planned two-hour ...
Colorectal cancer is the second leading cause of cancer death in the US. Furthermore, it's estimated that over 150,000 people ...
Background Lupus nephritis (LN) is the most serious complication of SLE. Interstitial fibrosis is the dominant pathological ...